3/10 · Low — ~6% forward revenue and ~9% forward EPS CAGR, decelerating; a mature conglomerate mid-breakup, not a multibagger
Technicals
Broken — see §7: a large discrepancy in the price-history feed (a spin-adjustment artifact) makes the moving-average signals unreliable; read with caution
Conviction
None — 0 expert voices in the Synthos KB; verdict rests entirely on fundamentals and quant
Position sizing
If owned at all, a small ~1–2% diversified-industrial satellite; not a conviction position
The 3-way corporate breakup — execution, dis-synergies and stranded costs could destroy value instead of unlocking it
One-line thesis. Honeywell is a cheap, low-beta, cash-generative industrial conglomerate in the middle of splitting itself into three — a classic "sum-of-the-parts" value setup where the reward (re-rating of Aerospace) is real but so is the execution risk, and with zero expert coverage and only mid-single-digit organic growth, it earns a Watch until the breakup terms and post-split earnings power are clearer.
◆ Synthos call — HoldHON is a solid business largely reflected at ~$235 — fine to keep, no reason to chase; it gets interesting again below ~$200.
Downside Risk (lower = safer)
5/10 · Moderate
Low beta 0.84 & cheap 16× trailing, but net-debt/EBITDA 3.4× is elevated and a 3-way breakup adds event risk.
Growth Quality
5/10 · Moderate
Mid-single-digit revenue & ~9% forward EPS CAGR, ~20% EBITDA margin, ROE 24% but ROIC only ~8% — steady, not special.
Exponential Potential
3/10 · Low
A mature $73B industrial conglomerate mid-breakup; decelerating, capped TAM-vs-cap — a compounder at best, not an exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 3%/yrTo justify today’s $230, earnings would have to compound roughly 3% a year for 10 years (9% discount rate). Analysts forecast ~9%/yr, so the market is pricing in LESS than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Honeywell is a 120-year-old industrial giant that makes a bit of everything: jet-engine parts and cockpit electronics (its biggest and best business), building-control and security systems, safety gear and warehouse-automation tech, and specialty chemicals and refining technology. Think of it as four solid, boring, profitable businesses bolted together.
The company has decided those businesses are worth more apart than together, so it is breaking itself into three separate companies. That's the whole story right now: if the split is done well, the pieces (especially Aerospace) could be worth more than the current stock price. If it's botched — extra costs, distracted management, businesses that were stronger together — it could go the other way.
On price, the stock is reasonably cheap for a company this steady (about 16× last year's earnings, with a 3.1% dividend), but it isn't growing fast. Our verdict is Watch — not cheap enough and not fast enough to buy with conviction, but not broken enough to avoid.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle of the road). The stock is steady (it doesn't swing much) and priced fairly, but the company carries a fair amount of debt and the breakup adds uncertainty.
Growth Quality 5/10 (average). A good, profitable business — but it grows slowly, in the mid-single digits, like the economy.
Exponential Potential 3/10 (low). This is a mature, giant company that is shrinking itself by splitting up. Don't expect it to double.
The one big worry: the three-way breakup. Corporate splits can unlock value — or they can leak it through duplicated costs and lost scale. Until the terms and the standalone numbers are on the table, nobody (including us) can price it precisely.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = HON · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$229.86
Market cap$73B
P/E trailing10×
P/E FY26E / FY27E21× / 19×
EV / Sales2.7×
EV / EBITDA13.4×
Gross margin36.9%
Net margin11.2%
Dividend yield3.10%
Beta0.843
52-wk range$222 – $496
RSI(14)16
50 / 200-DMA$424 / $426
12-mo return+-52% (SPY +21%)
Street target$251 ($220–$276)
Analyst grades18 Buy · 9 Hold · 1 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on HON · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Honeywell International (Nasdaq: HON) is a diversified technology-and-manufacturing conglomerate founded in 1906, headquartered in Charlotte, NC, run by CEO Vimal Kapur, with ~102,000 employees. Fiscal year ends December 31. In early 2025 management announced a plan to separate the company into three independent public companies — Aerospace, Automation, and Advanced Materials — the strategic event that dominates the investment case today.
Revenue mix (FY2025, from filings):
By product segment (as currently reported): Aerospace $17.51B (47%) · Safety & Productivity Solutions $9.40B (25%) · Home & Building Technologies $7.37B (20%) · Energy & Sustainability Solutions $3.13B (8%). (Note: FMP's segment labels shift year to year as Honeywell re-segments; FY24 and earlier used "Performance Materials & Technologies." Total FY25 revenue $37.44B.)
By geography: United States $21.78B (58%) · Europe $8.11B (22%) · Other International $7.55B (20%). Majority-US, with meaningful international cyclicality.
Aerospace is the crown jewel — highest growth, best margins, and the piece most likely to command a premium multiple as a standalone. The breakup thesis is essentially: let the market pay an aerospace multiple for aerospace and an industrial multiple for the rest, instead of a blended conglomerate discount on all of it.
2. The expert thesis
There is no expert coverage of Honeywell in the Synthos knowledge base. The claims file returns total_claims: 0, net_bullish_voices: 0, and an empty top array. No independent voice in our panel has published a traceable, distilled claim on HON.
Per house standard, we do not fabricate conviction. With no claim_id values to cite, this deep dive is explicitly fundamentals- and quant-driven: every judgment below rests on the FMP financials, analyst estimates, price-target consensus, and our own scenario model — not on borrowed expert conviction. Where the Street has a view we show it as context, not as our anchor.
This absence is itself information: Honeywell is a well-covered mega-cap by sell-side analysts (28 issue ratings) but does not feature in the high-signal, forward-looking expert panel Synthos tracks — consistent with a mature, "known-quantity" industrial that generates less differentiated forward insight than the exponential names the KB is built around.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Beta 0.84 and 16× trailing EPS with a 3.1% yield give real valuation support, but net-debt/EBITDA 3.4× is elevated for an industrial and the 3-way breakup injects event risk and potential stranded costs.
Growth Quality
5 · Average
~6% forward revenue CAGR and ~9% forward EPS CAGR, ~20% EBITDA margin, ROE 24% flattered by leverage — but ROIC only ~7.8%. Steady and well-run, not special.
Exponential Potential
3 · Low
A mature $73B conglomerate shrinking itself via breakup; growth is decelerating and the addressable-market-vs-cap runway is capped. A compounder at best.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Breakup executes cleanly; Aerospace re-rates toward a pure-play aero multiple; sum-of-the-parts is realized. FY27E EPS ~$12.4 (high estimate) at a blended ~24×.
~$300 (+30%)
Base(our anchor)
Estimates roughly hit — FY26E EPS $10.97, FY27E $11.97; a mid-single-digit grower with a partial SOTP re-rate earns a ~20× forward multiple on FY27E.
~$235 (+2%)
Bear
Breakup slips or leaks value (dis-synergies, stranded costs); cyclical softness in short-cycle segments; multiple stays a conglomerate ~15× on FY27E ~$11.4 (low estimate).
~$175 (−24%)
Synthos fair value = the base case, ~$235 (+2%), with the full $175–$300 span as the honest range. Our base sits below the Street's $251 consensus because we do not yet give the breakup full credit — the terms, standalone balance sheets, and dis-synergy costs are not fixed. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). HON is neither an exponential nor a top-tier compounder — it is a mature industrial in the middle of a restructuring:
Acceleration (the 2nd derivative) is flat-to-negative: revenue growth is projected in the mid-single digits and the FY26E EPS of $10.97 sits below FY25's reported $14.80 — a step-down that reflects the spin-off of businesses and reset of the earnings base, not a collapse in the underlying franchise. There is no growth inflection here to compound.
Room to run: at a $73B market cap in mature end-markets (commercial aerospace aftermarket, building controls, industrial automation, specialty materials), the addressable-market-vs-cap runway is limited. The one genuine "unlock" is corporate — the breakup — not a demand explosion.
Reinvestment runway: disciplined but modest — capex ~$1B/yr (2.8% of revenue), FCF ~$5.4B FY25; the story is capital return (dividends + buybacks) plus M&A, not high-ROIC organic reinvestment (ROIC ~7.8%).
Exponential Potential: Low (3/10). Own HON, if at all, for steady mid-single-digit compounding, a 3.1% dividend, and the event-driven possibility that the breakup surfaces value — not for exponential growth. This is a value/special-situation name, not a growth name.
Revenue: FY25 $37.44B, +7.9% (FY24 $34.72B, +5.2% on FY23 $33.01B). Steady mid-single-digit growth, boosted in FY24–25 by acquisitions (the FY24 cash flow shows ~$8.9B of acquisitions).
Quarterly trajectory: Q1'25 $9.82B → Q2 $10.35B → Q3 $10.41B → Q4'25 $6.86B (a low quarter reflecting a discontinued-operations reclassification) → Q1'26 $9.14B. Q4'25 booked a net loss of −$115M on non-operating charges — a reminder that spin-related noise is now in the numbers.
Margins: gross 36.9% TTM, EBITDA 19.8% TTM, operating ~14.9%, net 11.2% TTM. Respectable industrial margins, led by Aerospace.
Earnings: net income $4.73B FY25 (vs $5.71B FY24 — down on higher interest expense and charges); reported EPS $14.80 FY25. TTM diluted EPS ~$14.16; TTM net-income-per-share (FMP) $12.92.
Cash flow: operating CF $6.38B, capex −$0.99B, FCF $5.39B FY25 (FCF yield ~5.6%). Consistent, high-quality cash conversion — the ballast of the story.
Balance sheet: total debt $34.58B, net debt $22.09B, net-debt/EBITDA 3.4× — elevated for an industrial and up sharply from ~1.7× in FY23 after the debt-funded acquisition spree. Interest coverage ~3.9×. This leverage is the main balance-sheet caution and complicates the breakup (debt must be allocated across the three entities).
6. Valuation — priced in or room?
HON is reasonably valued, not cheap and not expensive: 16× trailing EPS, 2.65× EV/sales, 13.4× EV/EBITDA, ~5.6% FCF yield, 3.1% dividend yield. On forward estimates the multiple is 21× FY26E → 19× FY27E → 15× FY30E — note the forward P/E is higher than trailing because the FY26E EPS base ($10.97) resets below FY25's reported $14.80 as businesses are spun out. A PEG-style read on ~9% forward EPS growth at ~20× forward is full-ish for the growth rate; the value case leans on the sum-of-the-parts (Aerospace alone, as a standalone, would likely command a premium aero multiple) rather than on the blended P/E. Street targets (context): consensus $251, high $276, low $220 (18 Buy / 9 Hold / 1 Sell). Our $235 base is below consensus because we discount the breakup until terms firm up. FMP's letter rating is B+ (weak on debt-to-equity and P/B, decent on ROE/ROA). Fairly priced — a hold-and-watch, not a bargain.
7. Technicals (computed from EOD price history — DATA CAUTION)
Read this section with skepticism: the price-history feed is internally inconsistent for HON and the moving-average signals are unreliable.
The discrepancy: the tech block reports a 52-week high of $496.08, a 50-DMA of $424 and a 200-DMA of $426, versus a last price of $229.86 — implying a −54% drawdown and RSI of 16. But the quote block reports a 52-week range of only $195.87–$260.28 and 50/200-DMAs of $231 / $225. The two feeds disagree by ~2×. This is almost certainly a spin/split-adjustment artifact in the price series (Honeywell's separation and prior corporate actions), not a real 50% crash. We do not trust the tech-block moving averages or RSI here.
What we can say from the reliable quote feed: price $229.86 sits mid-range within a $196–$260 52-week band, essentially flat-to-slightly-below its own ~$231/$225 50/200-DMAs — i.e. a rangebound, un-trending stock, consistent with a name in restructuring limbo.
Beta 0.84 — lower-volatility than the market, as expected for a diversified industrial.
Relative strength: even taking the feed's return figures loosely, HON has lagged — SPY +20.6% and QQQ +30.3% over 12 months while HON traded sideways-to-down. No momentum tailwind.
Read: technicals offer no actionable edge here and are partly corrupted; the case is fundamental/event-driven. Do not use the −54%/RSI-16 figures as a buy signal — they are a data artifact.
8. Moat & competitive position
Honeywell's moat is installed-base and certification-driven, strongest in Aerospace: certified avionics, auxiliary power units and engine controls carry decades-long aftermarket annuities and high switching costs (re-certifying a replacement supplier is slow and expensive). Building Technologies and process-automation controls (Experion, UOP licensing) enjoy sticky, standards-based installed bases. The weaker links are the more commoditized safety/PPE and short-cycle industrial products. Overall: a wide-but-shallow moat — durable in aero and controls, cyclical and competitive elsewhere. The breakup is partly an admission that a single conglomerate multiple undervalues the strong-moat aero franchise.
Peer set (market cap, FMP): Deere $168B, Union Pacific $168B, Eaton $155B, Lockheed Martin $126B, Parker-Hannifin $121B, Trane $106B, General Dynamics $101B, ADP $97B, 3M $84B, Northrop Grumman $78B. Against pure-play aero (LMT, GD, NOC) and best-in-class industrials (ETN, PH, TT), HON's blended growth and multiple sit in the middle of the pack — the SOTP argument is precisely that its aero unit should trade nearer the defense/aero names once standalone.
9. Management, capital allocation & guidance
Capital allocation: balanced — FY25 returned ~$3.8B in buybacks and ~$3.0B in dividends (3.1% yield, long dividend-growth history) while funding ~$1B capex and ~$1B of bolt-on M&A. The FY24 debt-funded acquisition binge (~$8.9B) pushed net-debt/EBITDA to 3.4× — the one allocation misstep to watch, as it constrains flexibility into the breakup.
The breakup: the defining capital-allocation decision — separating into Aerospace, Automation, and Advanced Materials. Executed under CEO Vimal Kapur, it is the primary lever for value creation and the primary execution risk.
Insider activity: the most recent Form 4s (filed 2026-07-01, transacted 2026-06-29) are routine equity grants — CEO Kapur, CFO Stepniak and the General Counsel received stock-option awards (strike $200.61) and RSUs. These are compensation awards (A-Award), not open-market buys or discretionary sells — no signal either way.
Guidance: Honeywell is not represented in the Synthos KB, so we have no distilled management-guidance claims; forward figures here are FMP analyst consensus, labeled as estimates. Watch for updated standalone-entity guidance as the separation progresses.
10. Catalysts & what to watch
Next earnings: 2026-07-23 (Q2'26; Street EPS $4.83, revenue ~$9.55B). Watch organic growth by segment and any updated breakup timeline.
Breakup milestones: Form-10 filings, standalone financials, debt allocation across the three entities, and separation dates — each is a discrete re-rating (or de-rating) event.
Aerospace aftermarket: commercial-flight-hours and defense budgets drive the crown-jewel segment.
Short-cycle demand: Automation/Safety & Productivity are economically sensitive — a leading tell on industrial cyclicality.
Deleveraging: progress bringing net-debt/EBITDA back below ~3× would de-risk the split.
Thesis tripwires (what would change the call): breakup terms that reveal large stranded/dis-synergy costs; net-debt/EBITDA rising further; two consecutive quarters of organic-revenue decline; or an Aerospace margin stumble. Conversely, a clean separation with a credible SOTP would move us from Watch toward Buy — Tactical.
11. Key risks
Breakup execution (structural, the big one): three-way separations can leak value through duplicated corporate costs, lost cross-selling, stranded overhead, and debt-allocation friction. The unlock is not guaranteed.
Leverage: net-debt/EBITDA 3.4× is elevated and must be split across the new entities; higher-for-longer rates raise the ~$1.3B interest bill.
Cyclicality: short-cycle industrial and safety demand tracks the economy; a downturn pressures the non-aero segments.
Valuation offers only modest support: at ~20× forward for ~9% EPS growth, a disappointment has room to de-rate toward the bear's 15×.
No expert coverage / low differentiated insight: with zero KB voices, we lack the independent forward conviction that anchors our higher-confidence calls — a reason for humility, reflected in the Watch verdict.
12. Verdict, position sizing & monitoring
Watch. Honeywell is a well-run, cash-generative, low-beta industrial trading at a fair-but-not-cheap ~16× trailing / ~20× forward, in the middle of a three-way breakup that could surface real sum-of-the-parts value — or leak it. With no expert coverage in the Synthos KB, only mid-single-digit organic growth, elevated 3.4× leverage, and a base-case fair value (~$235) barely above today's price, there is no compelling edge to buy and no reason to avoid. The honest call is to wait for the breakup terms and standalone earnings power before committing.
Sizing: if held at all, a ~1–2% diversified-industrial/special-situation satellite — never a conviction position at this stage. Investors who want the SOTP optionality can take a starter and add as separation terms de-risk.
Monitoring: re-underwrite on each breakup milestone (Form-10s, standalone financials, debt allocation) and formally re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $229.86.
Single biggest risk: the three-way breakup — the entire upside case, and much of the downside, hinges on executing the separation without destroying value.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — Honeywell has no expert coverage in the Synthos knowledge base. This verdict is explicitly fundamentals- and quant-driven; no expert conviction is cited or implied. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates.
Data caveat: the technicals price-history feed is internally inconsistent (a spin/split-adjustment artifact); the 50/200-DMA, 52-week-high and RSI figures in the tech block are not trusted — see §7.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").